# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zelda Fitzgerald (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET004-SYN
- Date: 2026-05-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margot Ellery, MD
- Calendar frame: modern shifted

## What we are working on

- She wants to understand what happened and to make sure it never happens again **S**
- She wants to dance again and is afraid that medicines will make her gain weight **S**
- She is worried that her periods have stopped **S**

## Your goals

- No manic, depressive or psychotic episode and no readmission through six months. Target: 2026-10-26. Recorded outcome: No episode and no admission; lithium and aripiprazole continued. **S**
- Lithium trough level 0.6 to 0.8 mmol/L with normal kidney and thyroid tests at six months. Target: 2026-10-26. Recorded outcome: Lithium 0.72 mmol/L; creatinine 0.79 mg/dL; TSH 3.1 mIU/L. **S**
- Periods return and prolactin is normal by three months. Target: 2026-08-10. Recorded outcome: Periods returned five weeks after the switch to aripiprazole; prolactin 14 ng/mL. **S**
- BMI at least 19, with food matched to her training, by six months. Target: 2026-10-26. Recorded outcome: BMI 19.2 at 52.4 kg, dancing about four hours a day. **S**
- PHQ-9 score below 5 by six months. Target: 2026-10-26. Recorded outcome: PHQ-9 3. **S**

## What we agreed to do

- Continue the antipsychotic started in hospital, with monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose or A1c and lipids at baseline, 12 weeks and yearly, prolactin because her periods have stopped, side-effect checks, and the AIMS at baseline and every six months. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Psychiatry consultation with the first-episode psychosis coordinated specialty care team on the provisional diagnosis and how to settle it, a mood stabilizer to prevent another episode, and the antipsychotic choice given her raised prolactin and missed periods. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- Reproductive health on psychiatric medicines: a pregnancy test before any new medicine, valproate avoided because of its risks in pregnancy, counseling on the risks of any mood stabilizer in pregnancy, contraception that suits her, folic acid, and planning with psychiatry before any pregnancy. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024) **S**
- Eating and exercise: the SCOFF screen, menstrual and energy review at each visit, a sports dietitian, and a graded return to dance with food matched to the training load; training hours watched as an early warning sign. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**
- Coordinated specialty care: a care coordinator, individual therapy with psychoeducation about mood and psychosis, education for the people she chooses, support to return to dance and writing, and a peer specialist. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- Sleep and early warning signs: regular sleep and wake times, no all-night writing or training, and a plan to call the team after two short nights or if training hours climb. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) **S**
- Lithium carbonate 300 mg twice daily after a negative pregnancy test, with 12-hour trough levels 5 to 7 days after starting and after any change, then every 3 to 6 months (target 0.6 to 0.8 mmol/L); creatinine and eGFR every 2 to 3 months for 6 months, then every 6 to 12; TSH once or twice in the first 6 months, then every 6 to 12; calcium yearly; and sick-day rules: hold it during vomiting, diarrhea or dehydration, and avoid anti-inflammatory painkillers. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence (2023); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Switch from risperidone to aripiprazole: aripiprazole 10 mg daily with risperidone 1 mg for one week, then risperidone stopped; prolactin and periods checked at three months. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**
- Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, the PHQ-9 at each visit, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Lithium sick-day plan, written down and shared with her roommate with her consent: stop lithium during vomiting, diarrhea, fever with poor drinking, or heavy sweating without fluids, and call the clinic; restart when eating and drinking normally; no anti-inflammatory painkillers; and go to the emergency department for confusion, unsteadiness, slurred speech, or a coarse tremor. Guideline: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**

## Follow-up

- 2026-05-11: Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis and differential, antipsychotic monitoring baseline, missed periods, eating and exercise, and safety planning **S**
- 2026-05-18: One-week review and psychiatry consultation with the coordinated specialty care team **S**
- 2026-06-08: Lithium level after the sick visit, prolactin, and the antipsychotic plan **S**
- 2026-08-10: Three-month review: lithium, thyroid, kidney and metabolic checks, and the diagnosis reviewed **S**
- 2026-09-14: Periodic adult preventive visit with contraception **S**
- 2026-10-26: Six-month review: maintenance treatment, lithium monitoring, and movement check **S**

This teaching document does not replace care from a qualified clinician.
